Search Results
Site Search
Hereditary movement disorders - Insights
Learn about our advanced genetic testing for hereditary movement disorders, including ataxias, Huntington’s disease, and Parkinson’s disease.
6 Ways Individualized Medicine Is Advancing Patient Care - Insights
Keith Stewart, M.B., Ch.B., Carlson and Nelson Endowed Director, Mayo Clinic Center for Individualized Medicine, presented six ways precision medicine has further advanced into patient care over the past year.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 12 - Insights
This week’s Research Roundup highlights a mechanism for preventing asymmetric histone segregation onto replicating DNA strands.
Generating awareness of the laboratory - Insights
Medical Laboratory Professionals Week, an annual celebration held in April, is a great time to raise awareness of the impact the laboratory has on patients and providers in the community. Lab Week is also an opportunity to spotlight the...
Learn how reliable laboratory diagnosis of a platelet disorders can impact patients’ and their family members' clinical management and outcomes.
Talking omicron with Matthew Binnicker, Ph.D. - Insights
With the omicron variant grabbing headlines around the world, media outlets have turned to experts like Dr. Binnicker to help clarify the effect this new variant could have and what it might mean for the COVID-19 pandemic.
The Past, Present, and Future of Laboratory Automation - Insights
PACE / State of FL - This “Continual Improvement” webinar provides an overview of automating laboratory workflows and its impact on the overall efficiency of testing by speeding up tasks, minimizing waste, reducing reagent usage, and...
People Archives - Page 37 of 37 - Insights
Skip to Content MayoACCESS MayoLINK...
What's New in Quality and Regulatory Expectations for Laboratories? [2022] - Insights
PACE / State of FLThis “Continual Improvement” webinar will provide an overview of new or changed regulations for 2022, and other regulatory issues that have the potential to affect clinical laboratories. The latter half of the year has...
Phlebotomy Modules: Module 3 | Insights
Skip to Content MayoACCESS MayoLINK...
On the Sept. 2 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Justin Kreuter, M.D., Medical Director of Mayo’s Blood Donor Program, about new eligibility guidelines for blood donors with previous...
Mayo Clinic Laboratory and pathology research roundup: November 1 - Insights
This week's research roundup features: Alliance A071401: phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations
Find out more about how Mayo Clinic Laboratories’ pediatric testing covers the full range of clinical specialties.
In April 2021, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights
In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...
JoAnne Michael’s symptoms started with dizziness and forgetfulness before down spiraling into severe confusion, crying jags, and brain seizures. ER doctors at her local hospital initially thought she was on drugs. JoAnne, terrified,...
Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates customized collaborations with diagnostic companies to support their clinical and research testing needs.
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...
Familial Variant Targeted Testing (FMTT) - Insights
In this month's "Hot Topic," Megan Hoenig, M.S., M.P.H., CGC, a licensed and certified genetic counselor with the Division of Laboratory Genetics and Genomics at Mayo Clinic Laboratories, describes the principles and benefits of Familial...
Research Roundup Archives - Page 19 of 28 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 19 - Insights
This week’s Research Roundup highlights the association of apolipoprotein E ε4 with transactive response DNA-binding protein 43.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 10 - Insights
This week’s Research Roundup highlights hepatocellular carcinoma detection by plasma methylated DNA through a discovery, phase I pilot, and phase II clinical validation.
PathWays Case Studies: Nov. 2018 - Insights
Mayo Clinic laboratory experts share three case studies in this month’s “PathWays” post and are challenging you to test your Clinical Pathology, Molecular Diagnostic, Hematopathology, and Dermatology pathology knowledge. Review the cases,...
Mayo Clinic Start-up Earns World Economic Forum Award - Insights
Mayo Clinic startup company Vineti developed first-of-its-kind software package tracking for cell therapies. Vineti’s groundbreaking product captured a World Economic Forum Technology Pioneer Award in the field of health.
Training Clinical Chemistry: Where Do We Go from Here? - Insights
Justin Kreuter, M.D., discusses training in clinical chemistry, highlighting his own experiences and challenges and offering valuable resources for future pathology residents.
January 2023 - Gastroenterology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gastroenterology Pathology.
COVID-19 Laboratory Update: July 7 | Minnesota Partnership - Insights
Minnesota reaches milestone of 20,000 daily test capacity Minnesota Governor Tim Walz has announced the state has completed more than half a million
Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.
Discover cutting-edge movement disorder diagnostics at Mayo Clinic Laboratories, encompassing autoimmune and hereditary conditions.
Reviewing the challenges healthcare providers face in distinguishing between new and residual marijuana use in patients.
MCL GATA2 Gene Sequencing Patient Information MC1235249
MCL GATA2 Gene Sequencing Patient Information Complete print GATA2 Gene Sequencing Patient Information Reset Form Instructions accurate interpretation reporting genetic results
Malaria Laboratory Testing.indd
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 04/2021 Malaria Laboratory Testing Algorithm 1 Malaria can be a rapidly fatal disease, particularly when due to Plasmodium falciparum, and less commonly...
Infectious disease test gains U.S. FDA approval - Insights
An ideal testing partner will offer extensive expertise in assay development and analytical validation services, along with access to biospecimens. In this collaboration example, learn how Mayo Clinic Laboratories’ BioPharma Diagnostics...
Opioid Addiction and Substance Abuse Testing: Paul Jannetto, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Paul Jannetto, Ph.D., director of the Clinical and Forensic Toxicology Lab,...
A Test in Focus Archives - Page 3 of 11 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Antibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers From the Lab" podcast, Andrew McKeon,...
John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating...
New Panels Help Find Cause of Rapidly Progressive Dementia: Gregg Day, M.D. - Insights
Rapidly progressive dementia (RPD) is an umbrella term covering many devasting conditions, including Creutzfeldt-Jakob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' unique RPD evaluation and new CJD test...
Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D., explain how Mayo Clinic Laboratories' unique risankizumab panel measures levels of both that drug and its antibodies in patients' blood. The results can better guide the management of...
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 22 - Insights
This week’s Research Roundup highlights neoantigenic potential of complex chromosomal rearrangements in mesothelioma.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Operational updates - Insights
The latest operational updates from Mayo Clinic Laboratories, including holiday shipping schedules, information technology changes, and more.
Testing Archives - Page 16 of 25 - Insights
Skip to Content MayoACCESS MayoLINK...
April 2023 - Gynecological Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gynecological Pathology.
Serologic testing for celiac disease in patients with IgA deficiency - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses serologic testing for Celiac Disease in patients with IgA deficiency.
Research Archives - Page 29 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic Laboratory and pathology research roundup: December 14 - Insights
This week’s research roundup features: Renal Neoplasia in Polycystic Kidney Disease: An assessment of Tuberous Sclerosis complex-associated Renal Neoplasia and PKD1/TSC2 contiguous gene deletion syndrome.
Testing Archives - Page 8 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
STAT testing is available on a limited basis for patients with a suspected or known inborn error of metabolism when there is an increased risk of illness or death due to metabolic decompensation or when testing will allow for emergent...
lysosomal_storage_disorders_diagnostic_algorithm_part_2.pdf
If deficient, MLD confirmed One of the following suspected: ■ Aspartylglucosaminuria ■ α-Mannosidosis ■ β-Mannosidosis ■ Pompe disease ■ Sandhoff disease ■ Schindler disease ■ Sialidosis ■ Galactosialidosis* ■ α-Fucosidosis* ■...